1 | AHBBD, YY1AP1
|
| Loss-of-Function Mutations in YY1AP1 Lead to Grange Syndrome and a Fibromuscular Dysplasia-Like Vascular Disease.
|
| Guo DC, Duan XY, Regalado ES, Mellor-Crummey L, Kwartler CS, Kim D, Lieberman K, de Vries BB, Pfundt R, Schinzel A, Kotzot D, Shen X, Yang ML; University of Washington Center for Mendelian Genomics.
|
| Am J Hum Genet 100(1):21-30. doi: 10.1016/j.ajhg.2016.11.008.
2017
|
2 | YY1AP1
|
| Integrative genomics identifies YY1AP1 as an oncogenic driver in EpCAM(+) AFP(+) hepatocellular carcinoma.
|
| Zhao X, Parpart S, Takai A, Roessler S, Budhu A, Yu Z, Blank M, Zhang YE, Jia HL, Ye QH, Qin LX, Tang ZY, Thorgeirsson SS, Wang XW.
|
| Oncogene 34(39):5095-104. doi: 10.1038/onc.2014.438.
2015
|
3 | MAD2L2, YY1AP1
|
| Hepatocellular carcinoma-associated gene 2 interacts with MAD2L2.
|
| Li L, Shi Y, Wu H, Wan B, Li P, Zhou L, Shi H, Huo K.
|
| Mol Cell Biochem 304(1-2):297-304.
2007
|
4 | NPPA, TBX5, WWTR1, YY1AP1
|
| A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.
|
| Murakami M, Nakagawa M, Olson EN, Nakagawa O.
|
| Proc Natl Acad Sci U S A 102(50):18034-9. Epub 2005 Dec 6. 2005
|
5 | YY1, YY1AP1
|
| YY1AP, a novel co-activator of YY1.
|
| Wang CY, Liang YJ, Lin YS, Shih HM, Jou YS, Yu WC.
|
| J Biol Chem 279(17):17750-5.
2004
|
6 | YY1AP1
|
| [Clone of a novel liver cancer associated gene and analysis of the secondary structures of the predicted protein]
|
| Wang Z, Hu G, Wang H, Wu M.
|
| Zhonghua Gan Zang Bing Za Zhi 10(1):25-7. Chinese. 2002
|
7 | YY1AP1
|
| Identification and characterization of a novel human hepatocellular carcinoma-associated gene.
|
| Wang ZX, Wang HY, Wu MC.
|
| Br J Cancer 85(8):1162-7. 2001
|